Europe launches unified approach to spotting Alzheimer's before symptoms appear

A new European research consortium is standardizing amyloid imaging methods to identify Alzheimer's disease in its earliest stages, before cognitive decline occurs. The collaboration could reshape clinical trials, accelerate drug development, and influence how health systems screen and monitor at-risk populations.

Originaltitel: The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact